SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'AW2'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NW3_A_SAMA500_0 (HISTONEMETHYLTRANSFERASEDOT1L) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 8 / 12 | ASP A 161GLY A 163VAL A 169ALA A 188PHE A 223LEU A 224ASN A 241PHE A 245 | AW2 A 502 (-2.9A)AW2 A 502 (-3.2A)AW2 A 502 (-4.4A)AW2 A 502 (-3.6A)AW2 A 502 (-3.4A)AW2 A 502 ( 4.3A)AW2 A 502 (-4.3A)AW2 A 502 (-4.3A) | 0.34A | 1nw3A-4er6A:42.1 | 1nw3A-4er6A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZZ_A_SAMA635_0 (ACLACINOMYCIN-10-HYDROXYLASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163GLY A 165GLU A 186ASP A 222PHE A 223 | AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-2.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A) | 0.84A | 1qzzA-4er6A:3.9 | 1qzzA-4er6A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZZ_A_SAMA635_0 (ACLACINOMYCIN-10-HYDROXYLASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163GLY A 165GLU A 186PRO A 191ASP A 222 | AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-2.6A)AW2 A 502 ( 4.8A)AW2 A 502 (-3.5A) | 0.74A | 1qzzA-4er6A:3.9 | 1qzzA-4er6A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XDS_A_SAMA5635_0 (PROTEIN RDMB) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163GLY A 165GLU A 186ASP A 222PHE A 223 | AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-2.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A) | 0.85A | 1xdsA-4er6A:10.2 | 1xdsA-4er6A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XDS_A_SAMA5635_0 (PROTEIN RDMB) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163GLY A 165GLU A 186PRO A 191ASP A 222 | AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-2.6A)AW2 A 502 ( 4.8A)AW2 A 502 (-3.5A) | 0.86A | 1xdsA-4er6A:10.2 | 1xdsA-4er6A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XDS_B_SAMB9635_0 (PROTEIN RDMB) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163GLY A 165GLU A 186ASP A 222PHE A 223 | AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-2.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A) | 0.82A | 1xdsB-4er6A:10.9 | 1xdsB-4er6A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XDS_B_SAMB9635_0 (PROTEIN RDMB) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163GLY A 165GLU A 186PRO A 191ASP A 222 | AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-2.6A)AW2 A 502 ( 4.8A)AW2 A 502 (-3.5A) | 0.82A | 1xdsB-4er6A:10.9 | 1xdsB-4er6A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NXE_B_SAMB303_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | ASP A 161LEU A 162GLY A 163GLY A 165ASN A 241 | AW2 A 502 (-2.9A)NoneAW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-4.3A) | 0.73A | 2nxeB-4er6A:11.9 | 2nxeB-4er6A:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_D_VIBD223_1 (THIAMINEPYROPHOSPHOKINASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 4 / 8 | HIS A 315LEU A 143SER A 268ASN A 241 | NoneAW2 A 502 ( 4.4A)NoneAW2 A 502 (-4.3A) | 0.95A | 3lm8B-4er6A:2.43lm8D-4er6A:2.2 | 3lm8B-4er6A:17.513lm8D-4er6A:17.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QOW_A_SAMA417_0 (HISTONE-LYSINEN-METHYLTRANSFERASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLN A 168ALA A 188ASP A 222PHE A 223ASN A 241 | NoneAW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A)AW2 A 502 (-4.3A) | 0.85A | 3qowA-4er6A:40.9 | 3qowA-4er6A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QOW_A_SAMA417_0 (HISTONE-LYSINEN-METHYLTRANSFERASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 7 / 12 | GLY A 163VAL A 169ALA A 188ASP A 222PHE A 223ASN A 241PHE A 245 | AW2 A 502 (-3.2A)AW2 A 502 (-4.4A)AW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A)AW2 A 502 (-4.3A)AW2 A 502 (-4.3A) | 0.40A | 3qowA-4er6A:40.9 | 3qowA-4er6A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QOW_A_SAMA417_0 (HISTONE-LYSINEN-METHYLTRANSFERASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | GLY A 163VAL A 170ALA A 188ASP A 222PHE A 223 | AW2 A 502 (-3.2A)NoneAW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A) | 1.33A | 3qowA-4er6A:40.9 | 3qowA-4er6A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L4B_A_CAMA502_0 (CAMPHOR5-MONOOXYGENASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 4 / 8 | PHE A 159THR A 177VAL A 144VAL A 267 | NoneNoneAW2 A 502 ( 4.9A)AW2 A 502 (-4.8A) | 0.88A | 4l4bA-4er6A:undetectable | 4l4bA-4er6A:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V32_A_EF2A151_1 (CEREBLON ISOFORM 4) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 4 / 7 | ASN A 241PRO A 130PHE A 243PHE A 272 | AW2 A 502 (-4.3A)NoneNoneNone | 1.47A | 4v32A-4er6A:undetectable | 4v32A-4er6A:16.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZJ8_A_SUVA2001_1 (HUMAN OX1R FUSIONPROTEIN TO P.ABYSIIGLYCOGEN SYNTHASE) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | ALA A 273VAL A 293VAL A 249MET A 260PHE A 223 | NoneNoneNoneNoneAW2 A 502 (-3.4A) | 1.23A | 4zj8A-4er6A:4.2 | 4zj8A-4er6A:21.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MVS_A_ADNA401_1 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 6 / 7 | GLY A 163GLU A 186ALA A 188ASP A 222PHE A 223ASN A 241 | AW2 A 502 (-3.2A)AW2 A 502 (-2.6A)AW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A)AW2 A 502 (-4.3A) | 0.50A | 5mvsA-4er6A:41.6 | 5mvsA-4er6A:80.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MVS_B_ADNB401_1 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 7 / 8 | GLY A 163GLU A 186ALA A 188ASP A 222PHE A 223ASN A 241PHE A 245 | AW2 A 502 (-3.2A)AW2 A 502 (-2.6A)AW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A)AW2 A 502 (-4.3A)AW2 A 502 (-4.3A) | 0.44A | 5mvsB-4er6A:41.6 | 5mvsB-4er6A:80.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_B_SAMB601_0 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 12 | ASP A 161PRO A 191LEU A 224ASN A 241PHE A 223 | AW2 A 502 (-2.9A)AW2 A 502 ( 4.8A)AW2 A 502 ( 4.3A)AW2 A 502 (-4.3A)AW2 A 502 (-3.4A) | 1.39A | 5ybbB-4er6A:undetectable | 5ybbB-4er6A:23.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NJ9_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 7 / 12 | ASP A 161GLY A 163GLY A 165GLN A 168ALA A 188ASP A 222PHE A 223 | AW2 A 502 (-2.9A)AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)NoneAW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A) | 0.61A | 6nj9K-4er6A:35.5 | 6nj9K-4er6A:99.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NJ9_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 7 / 12 | ASP A 161GLY A 163GLY A 165VAL A 169ALA A 188ASP A 222PHE A 223 | AW2 A 502 (-2.9A)AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-4.4A)AW2 A 502 (-3.6A)AW2 A 502 (-3.5A)AW2 A 502 (-3.4A) | 0.48A | 6nj9K-4er6A:35.5 | 6nj9K-4er6A:99.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NQA_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 6 / 10 | ASP A 161GLY A 163GLY A 165VAL A 169ASN A 241PHE A 245 | AW2 A 502 (-2.9A)AW2 A 502 (-3.2A)AW2 A 502 (-3.5A)AW2 A 502 (-4.4A)AW2 A 502 (-4.3A)AW2 A 502 (-4.3A) | 0.55A | 6nqaK-4er6A:33.9 | 6nqaK-4er6A:99.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NQA_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4er6 | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC (Homosapiens) | 5 / 10 | ASP A 161GLY A 165VAL A 169GLU A 186PHE A 245 | AW2 A 502 (-2.9A)AW2 A 502 (-3.5A)AW2 A 502 (-4.4A)AW2 A 502 (-2.6A)AW2 A 502 (-4.3A) | 0.94A | 6nqaK-4er6A:33.9 | 6nqaK-4er6A:99.76 |